BIO (BioProtocol) fluctuates 41.0% in 24 hours: Driven by PEPTAIIgnitionSale oversubscription and trading volume surge
Bitget Pulse2026/05/02 13:35Volatility Brief
In the past 24 hours, BIO price rebounded from a low of $0.03964 to a high of $0.05590, currently trading at $0.05561, with an overall price swing of 41.0%. Trading volume has surged significantly, with a 24-hour turnover exceeding $45 million, at times reaching 25 times the average level; Open Interest (OI) has spiked 43.8%, and the funding rate has turned negative to -0.023%, indicating increasing pressure on shorts.
Brief Analysis of the Move
• Bio Protocol officially launched the PEPTAI Ignition Sale (AI agent project for peptide drugs), exceeding 5.9 times the subscription in just 30 minutes after going live, 20% of the supply was allocated to BIO stakers, incentivizing staking and USDC participation, thus driving active trading.
• Trading volume soared 207%, led by buying momentum (196K USDT within 15 minutes), with open interest rising in tandem. The negative funding rate intensified the short squeeze, resulting in a rapid price surge.
• The DeSci sector rotation has accelerated, while market attention grew due to the upgrade of BioXP and listing rumors on Upbit Korea, pushing turnover up to the $300 million level.
Market View and Outlook
The prevailing community sentiment is bullish, with long positions dominating on X, viewing the current situation as an opportunity for DeSci+AI biotech sector rotation. The target price is $0.048-$0.055, but the risk of a short-term squeeze is high (RSI at 78, indicating overbought conditions); analysts advise caution regarding a potential pullback to the $0.032-$0.037 support zone, and recommend monitoring the progress of the PEPTAI sale and staking data. If the price holds above $0.041, it is advised to maintain long positions.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for information purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. business growth drops to lowest in a year, stock price plunges 19% year-to-date! McDonald's (MCD.US) urgently changes leadership to rebuild "cost-effectiveness" defense line
Same-store sales growth in the United States fell to 0.8%, reaching a new low in over a year. McDonald's is urgently adjusting its strategy, planning to implement long-term affordable pricing, temporary discounts, and suspension of random inspections to optimize the service experience, making every effort to restore customer traffic and stock price.
IperionX validates technology to scale US titanium production
Fed Rate Hike Adds More Pressure as U.S. Mortgage Rates Rise for Four Consecutive Weeks, Approaching 7%, Housing Market Recovery May Be Further Delayed
Freddie Mac reported on Thursday that as of September 17, the average 30-year fixed mortgage rate in the United States rose to 6.95%, up from 6.76% the previous week. This marks the fourth consecutive weekly increase and the highest level since January 2025.
Overnight U.S. Stocks | U.S. Weekly Initial Jobless Claims Unexpectedly Decline, Three Major Indexes Close Higher, Intel (INTC.US) Surges Over 7.6%
At the close, the Dow Jones index rose by 316.14 points, or 0.61%, to 51,778.04 points; the S&P 500 index gained 85.91 points, or 1.14%, to 7,637.72 points; and the Nasdaq Composite index increased by 439.87 points, or 1.69%, to 26,418.30 points.
